Advertisement

Topics

EC approves Bayer's hepatocellular carcinoma drug

05:00 EDT 10 Aug 2017 | SmartBrief

The European Commission approved the use of Bayer's Stivarga, or regorafenib, in adult patients with hepatocellular carcinoma -More

Original Article: EC approves Bayer's hepatocellular carcinoma drug

NEXT ARTICLE

More From BioPortfolio on "EC approves Bayer's hepatocellular carcinoma drug"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...